Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
HL237
DRUG
2 trials
Sponsors
Hanlim Pharm. Co., Ltd.
Conditions
Rheumatoid Arthritis
Phase 1
A Single Ascending Dose Clinical Trial to Find the Maximum Tolerable Dose of HL237 in Healthy Male Subject
Completed
NCT03278470
Hanlim Pharm. Co., Ltd.
Rheumatoid Arthritis
Start: 2017-06-26
End: 2018-03-19
Updated: 2018-08-17
A Multiple Dose of HL237 in Healthy Male Subject
NCT03896594
Hanlim Pharm. Co., Ltd.
Rheumatoid Arthritis
Start: 2018-12-24
End: 2019-09-30
Target: 36
Updated: 2019-04-02